TABLE 1.
Details of patients studied
| Patient | Age | Status | Disease stagec | CD4 count (cells/mm3) | Neurological involvement | Sample(s) |
|---|---|---|---|---|---|---|
| P3 | Adult | Homosexual | B2 | 330 | No | Blood, semen |
| P31 | Adult | Homosexual | C3 | 130 | No | Blood, semen |
| P43 | Adult | Homosexual | A1 | 620 | No | Blood, semen |
| P-1206 | Neonate | MTCTa | C2 | 1,119 | No | Plasma |
| C3 | 218 | Yes | Plasma | |||
| P-1114 | Neonate | Sexual | A2 | 660 | No | Plasma |
| A2 | 1,108 | No | Plasma | |||
| C3 | 46 | Yes | Plasma | |||
| P-1031 | Neonate | MTCT | N1 | 2,147 | No | Plasma |
| C2 | 250 | Yes | Plasma, CSF | |||
| NA118 | Adult | IVDUb | C3 | 80 | Yes | Frontal lobe, lymph node |
| NA420 | Adult | Heterosexual | C3 | 12 | Yes | Frontal lobe, lymph node |
| NA20 | Adult | Hemophiliac | C3 | 4 | Yes | Frontal lobe, lymph node |
| NA176 | Adult | IVDU | C3 | 20 | Yes | Frontal lobe, lymph node |
| NA353 | Adult | IVDU | C3 | 2 | Yes | Frontal lobe |
a
MTCT, mother-to-child transmission.
b
IVDU, intravenous drug user.
c
CDC disease stage classification.